NEW YORK (GenomeWeb) – Malaysian diagnostics firm Medical Innovation Ventures (Mediven) said that it received the CE-IVD mark for its molecular diagnostic tests for influenza and cholera. 

Its GenoAmp Real-Time RT-PCR kit for influenza A and B detects influenza A serotypes H1N1 and H3N2, and influenza B from viral RNA in a single tube within four hours, the company said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.